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ScienceDirectCognitive problems are consistently documented in people with
schizophrenia. They negatively influence functioning and
contribute to the long term consequences of the illness.
Cognitive remediation (CR) is a psychological intervention
developed to target these cognitive difficulties. There is evidence
that CR is beneficial but there is still a limited understanding of
how the putative active therapy ingredients contribute to
changes in the brain and translate into improved functioning.
This paper reviews recent research focused on topics that, in our
view, will drive future developments such as the identification
of translational mechanisms, the personalisation of CR, the
best implementation methods and potential augmenting
strategies to improve treatment effectiveness.
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Introduction
In schizophrenia cognitive problems precede illness onset
and are evident from an early age [1,2]. These deficits are
associated with functional outcomes and are considered
rate limiting factors for recovery, even when high quality
rehabilitation is provided [3]. This was the driving force
behind the development of behavioural training aimed at
treating cognitive difficulties in people with psychosis [4].
These programmes are referred to under the umbrella term
of cognitive remediation (CR) or cognitive training. There
is now overwhelming evidence that CR is modestly effec-
tive in improving cognition and functioning but what is not
clear is how it should be provided, to whom, in what doses
and how we can boost its effects. There are many reasons
for this lack of knowledge but here we consider what we do
know that can aid personalisation using the latest literature
on the potential underlying mechanisms, the treatment
context for boosting effects and which patients benefit the
most and for whom are current systems ineffective.www.sciencedirect.com A consensus on CR
Increasing efforts have been made to define what consti-
tutes CR. This is particularly important in light of recent
claims suggesting that CR programmes improve work
performance or slow brain ageing. These claims, as the
scientific community has pointed out, are largely specula-
tive and not supported by strong evidence [5,6]. In fact a
large population based study [7] showed that it only
improved performance on the tasks trained and did not
generalise to cognitive functions. The lack of support for
commercial companies’ promises prompted a reflection
from the scientific community on the definition of CR.
Questions such as ‘what are the active components and
treatment targets?’ are increasingly central to a full under-
standing of CR’s potential. CR applications to mental
health problems are relatively common [8,9]. For psy-
chotic disorders the Cognitive Remediation Experts Work-
ing group defines CR as: ‘a behavioural-training based
intervention that aims to improve cognitive processes
(i.e. attention, memory, executive function, social cogni-
tion, or metacognition) with the goal of durability and
generalization’ where social cognition is defined as ‘the
mental operations that underlie social interactions includ-
ing perceiving, interpreting, and generating responses to
the intentions, dispositions, and behaviours of others’.
Two ‘schools’ of CR have dominated the field. The drill
and practice approach which proposes that cognitive
improvement can be obtained primarily by frequent
and intensive task practice tailored to the individual’s
ability. The alternative approach suggests that tasks
practice should be supplemented by strategy use to
increase the potential for generalisation to real world
problems. This distinction is similar to the distinction
between ‘top-down’ or ‘bottom-up’ approaches. Top-
down programmes preferentially target higher order cog-
nitive functions, such metacognition and executive func-
tion, and encourage a strategic approach to task practice.
Bottom-up approaches tend to preferentially train basic
attentional and perceptual skills. The growing consensus
is that they may not be as distinct as previously thought
[10]. Studies of moderators and mediators of the treat-
ment effects will contribute to clarifying the role of
intensive training and strategy use but also to characterise
the active building blocks of CR.
What is the mechanism underlying the
treatment effect? Integrating explanations
Despite consensus on neuroplasticity being an important
factor there is still limited evidence on how CR can orCurrent Opinion in Behavioral Sciences 2015, 4:147–151
148 Cognitive enhancementdoes enhance this process. Evidence from human studies
is still scarce but studies conducted in non-human pri-
mates suggest that cortical reorganisation may have a
unique relationship with task practice [11].
CR has been shown to improve frontal activity [12],
prevent grey matter decay [13], improve brain network
efficiency [14] and task-related blood flow in frontotem-
poral areas [15]. These are important, but mainly unre-
markable, findings as it is unlikely that cognitive
improvement could occur without change in the way
the brain functions, although preventing grey matter loss
is a surprising benefit. However, we still lack a precise
understanding of how CR programmes produce these
brain effects as they were achieved with different pro-
grammes, different numbers of sessions, with and without
a therapist.
The application of a translational framework to CR re-
search may overcome this problem (see Figure 1). The
dopamine hypothesis of schizophrenia has been the sin-
gle most influential theory in our understanding of the
neurochemical basis of schizophrenia. The hypothesis
assumes that psychotic symptoms, such as hallucination
and delusions, are caused by a hyperdopaminergic state
associated with increased phasic activity in subcortical
regions [16]. We know that the dopamine system is alsoFigure 1
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such as motivation, hedonic response and learning [17]
and these features are correlated with perturbation in the
prefrontal cortical regions. By identifying behavioural
correlates related to these effects we can link biological
abnormalities with cognition and define intervention
targets. Reward learning (RL) is one such cognitive
process which is responsible for proficiency in a variety
of tasks and is implicated in learning, motivation and
pleasure experiences. There is consensus that prefrontal
cortical regions are important in mediating this process
and that people with schizophrenia have very specific
difficulties in accomplishing tasks requiring RL [18].
Basic studies conducted on animals and healthy volun-
teers have linked RL and cognitive training with brain
neuroplastic changes and alteration in dopaminergic
action [19,20]. More recent animal models and pilot
clinical trials also suggest that glutamatergic and
GABAergic systems may be relevant targets to improve
cognition in people with schizophrenia and may be asso-
ciated with RL processes [21,22]. However, evidence in
this area is scarce and mostly based on animal studies.
RL is particularly difficult to track but novel computa-
tional methods applied to complex and detailed responses
from cognitive tasks do now allow us to surface elements
of RL relevant to improved cognitive performance. In ar Cognitive Remediation in
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Table 1
Current evidence in support of augmentation and boosting
methods for CR
Augmenting and
boosting CR
Method Example Results
Medication D-Cycloserine, modafinil,
oxytocin
Disappointing
Neuromodulation Transcranial direct current
stimulation
Not enough
evidence
Vocational support Supported employment Supported
by evidence
Psychological therapy Social cognition, CBT Promising
Physical exercise Aerobic activity programme Not enough
evidencerecent study using these techniques we demonstrated
that CR significantly improves sensitivity to reward and
negative feedback [23]. These results demonstrate, for
the first time, that a course of behavioural training based
on extensive practice and strategy use has an effect on a
core feature of schizophrenia — impaired RL. Beha-
vioural research suggests that by acting on the reward
system we may be able to target other important features
of the illness such as poor motivation and anhedonia [24].
Clearly more work is needed to explore the components
of CR more likely to affect RL and how improvements in
this domain translate into recovery milestones for
patients. However, these findings are promising and
may lead to a more integrated understanding of how
CR influences brain plasticity.
Boosting treatment effects through CR
augmentation
The metaphor of the brain as a muscle and CR as gym
training has prompted psychopharmacological research to
explore agents that may work as ‘brain steroids’ for
cognition (also referred to as procognitive agents). The
number of cognitive enhancing drugs has recently
increased opening up the potential for combining beha-
vioural and pharmacological treatments for cognitive pro-
blems in schizophrenia [25,26]. This is based on the
steroids and training metaphor. But it is not at all clear
that the key elements of CR are based solely on task
practice. More recent models use pedagogical knowledge
which tends to downgrade practice and foreground meta-
cognitive aspects of CR, for instance in the recently
developed CIRCuiTS programme [27]. This may be
why the field of pharmacological interventions has been
disappointing. For instance, Cain et al. [28] conducted one
of the first RCTs augmenting CR with a D-cycloserine to
improve its effect on memory. But only trained tasks
improved and this did not generalise to cognitive perfor-
mance. Modafinil also showed effects on task learning but
no generalisation in healthy volunteers and neither effect
in people with schizophrenia [29,30]. A further two stud-
ies augmenting social cognition training with oxytocin
also showed limited or no benefits compared to the
placebo [31,32]. All these studies used mainly task prac-
tice with no strategy instruction. These negative results
suggest an investigation of potential moderators of action
not least the type of patients and the type of CR provided.
Many studies (but not all) were relatively short and using
the blunt instrument of cognitive tests may never have
found subtle changes in performance across the varying
cognitive profiles of the participants. Without a more
personalised approach it is likely that we will miss
important signals from adding procognitive drugs. More
promising studies, however, are emerging using neuro-
modulation approaches. For example, repeated applica-
tions of transcranial direct current stimulation
demonstrate increased cortical excitability and plasticity
[33]. To date there are no controlled studies using thiswww.sciencedirect.com method in combination with CR in people with schizo-
phrenia but preliminary evidence from case studies shows
encouraging results [34] (see Table 1).
Unlike pharmacological augmentation, combining CR
with other behavioural interventions has shown more
positive results. The underlying rationale is that cognitive
improvements need to be exercised and that other reha-
bilitation programmes provide this opportunity. For ex-
ample, CR is most effective in achieving functional
outcomes when delivered in combination with supported
employment [35,36]. CR has also been combined with
other psychological therapies and demonstrated boosted
outcomes, for example, Lindenmayer et al. [37]. A recent
RCT combining CR with cognitive behavioural therapy
(CBT) compared to an active control [38] showed a
reduction in the number of CBT sessions to achieve
the same outcome. These studies suggest the possible
cost benefit of combining CR with other treatments.
Studies have also explored the potential benefits of
combining CR with physical exercise. Aerobic exercise
has been associated with increased production of brain
neurotropic factor and increased synaptic plasticity [39].
Preliminary studies exploring the effects of physical
exercise alone in people with schizophrenia yielded
encouraging results suggesting that this intervention
alone may be able to increase hippocampal volume
[40]. This technique would also promote other general
health benefits which for people with schizophrenia
might contribute to reduced mortality risk [41].
These findings suggest that CR exerts its maximal benefit
when delivered in the context of other rehabilitative
interventions but not with additional cognitive enhancing
or pro-cognitive drugs. It is still uncertain whether any of
these combination studies could have increased benefits
when more tailored to individuals — identifying sub-
groups might also allow us to see signals with pharma-
cological augmentation.Current Opinion in Behavioral Sciences 2015, 4:147–151
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Identifying characteristics that indicate the most treat-
ment benefit is not only important for individuals but also
for the rational allocation of resources in health care.
These concepts are therefore increasingly used in treat-
ment research and the field of CR is no exception. The
identification of personalising factors has now become
complex with interactions between genotype, medication
and CR that seem to influence treatment responses. For
instance individuals receiving clozapine showed cogni-
tive improvement after a course of CRT independently
from their genotypic profile [42]. However, those with the
val/val variant of the COMT gene who did not receive
clozapine did not show an improvement. A similar study
showed an association between a set of nucleotides of the
COMT gene and improvement in global cognition fol-
lowing CR [43].
Benefits seem to be larger in younger participants [44]
and this might be explained in terms of windows of
neuroplastic sensitivity so that targeted training at an
early stage of the disorder may achieve larger changes
[45]. Cognitive reserve has also been identified as a
potential predictive factor [46] as this determines the
individual’s learning potential. Finally, functional status
at intake to CR has also been shown to be an important
stratification variable as those with the poorest function-
ing seem to derive the most benefit from a combined CR
plus supported employment treatment [35]. Many of
these characteristics have been indicated post hoc in
secondary analyses on relatively small samples. The
forthcoming Database of Cognitive Training and Reme-
diation Studies (DoCTRS) set up by NIMH should
provide larger datasets to examine these potential bene-
ficial (and detrimental) characteristics for CR.
Conclusions
CR techniques have positive, but modest, effects on
cognitive difficulties in people with schizophrenia but it
remains the only targeted intervention available for cog-
nitive problems [47]. It has considerable advantages
including safety, acceptability and, in association with
other rehabilitative approaches, the promotion of recovery.
The personalisation agenda has started to form advanced
by secondary analyses of (usually) non-significant results
[48]. But many of these findings are not grounded in theory
and this is where there needs to be more focus. Future
studies can then begin to clarify the active therapy mecha-
nism that fosters neuroplasticity and which will lead to
durable effects on recovery. There is also a need to conduct
more research bridging the gap between clinical practice
and basic neuroscience. We have proposed a model
highlighting some translational stages that may help
researchers and clinicians to incorporate the next level
up or down in their research (Figure 1). We hope this
framework will contribute linking our knowledge ofCurrent Opinion in Behavioral Sciences 2015, 4:147–151 biological mechanisms to therapy procedures and guide
the future developments of CR.
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